Update: The CINP continues to monitor the global pandemic and its impact on international travel, and considers adding a virtual component to the 2022 Congress. At this time, we encourage all interested presenters to submit your symposia proposal, even if you are not certain yet whether you will be able to attend the 2022 Congress in person. A final decision regarding the format of the symposia will be made closer to the Congress.
Symposia of 90 min duration integrate the latest advances in basic, clinical, and translational neuropsychopharmacology, biological psychiatry, drug development public policy issues relevant to mental health, mental illness, and treatment across the lifespan.
Four Speakers including the Chairperson should represent at least three different countries and four different institutions. It is recommended that at least two speakers should be CINP members. Symposia proposals that include female faculty and investigators who obtained their last degree in the last 10 years are greatly encouraged.
The individual who submits the symposium proposal via the submission process below must be the Chairperson of their proposed session.
Submitters can apply for no more than two symposia and speakers can agree to participate in no more than two proposals.
CINP 2022 Symposia will be reviewed and selected on a highly competitive basis by the International Scientific Programme Committee in October 2021. Notifications will be sent to all symposia submitters in November 2021.
Speakers in successful symposia will receive the following entitlements:
|Symposia Submission Deadline||October 10, 2021 (23:59 GMT+8)|
|Notification of Submission Acceptance||November 8, 2021|
|Deadline for Change of Title/Authorship||October 10, 2021|
Abstract submissions must be structured with the following:
All submitted proposals will be reviewed by the International Scientific Programme Committee and submitters will be informed whether successful or otherwise in November 2021.
Each proposal will be judged on objective evidence on the following criteria:
The CINP International Scientific Programme Committee welcomes the proposal of symposia that link the latest, and ground-breaking, preclinical developments with the clinical research on a given topic. Through the free and open exchange of ideas, CINP supports a strong focus on new approaches to the development and assessment of CNS pharmaceuticals by researchers working in both academia and industry. Please find below the list of topics:
Stay tuned for more information on upcoming Congresses hosted by the International College of Neuropsychopharmacology (CINP).
Keep up to date with Congress News & Alerts